CAMK2G and breast carcinoma: More recently, Pak1 was shown to directly phosphorylate and activate CaMKII in breast cancer, and dual inhibition of Pak1 and CaMKII synergistically reduced proliferation, migration, invasion, and xenograft growth in triple-negative and Her2+ models [80].